Application Prospects of Triphenylphosphine-Based Mitochondria-Targeted Cancer Therapy
Open Access
Abstract
Cancer is one of the leading causes of death and the most important impediments to the efforts to increase life expectancy worldwide. Currently, chemotherapy is the main treatment for cancer, but it is often accompanied by side effects that affect normal tissues and organs. The search for new alternatives to chemotherapy has been a hot research topic in the field of antineoplastic medicine. Drugs targeting diseased tissues or cells can significantly improve the efficacy of drugs. Therefore, organelle-targeted antitumor drugs are being explored, such as mitochondria-targeted antitumor drugs. Mitochondria is the central site of cellular energy production and plays an important role in cell survival and death. Moreover, a large number of studies have shown a close association between mitochondrial metabolism and tumorigenesis and progression, making mitochondria a promising new target for cancer therapy. Combining mitochondrial targeting agents with drug molecules is an effective way of mitochondrial targeting. In addition, hyperpolarized tumor cell membranes and mitochondrial membrane potentially allow selective accumulation of mitochondria-targeted drugs. This enhances the direct killing of tumor cells by drug molecules while minimizing the potential toxicity to normal cells. In this review, we discuss the common pro-mitochondrial agents, the advantages of triphenylphosphine (TPP) in mitochondrial-targeted cancer therapy and systematically summarize various TPP-based mitochondria-targeting anticancer drugs.Keywords
Funding Information
- National Natural Science Foundation of China (81870591, 212102310874, 222102310013, 222102310290, 23A310011, 22A310001, 2203012, 202210475148, 202210475027)
- Key R&D and promotion projects in Henan Province (81870591, 212102310874, 222102310013, 222102310290, 23A310011, 22A310001, 2203012, 202210475148, 202210475027)
- Key Scientific Research Projects of Colleges and Universities in Henan Province (81870591, 212102310874, 222102310013, 222102310290, 23A310011, 22A310001, 2203012, 202210475148, 202210475027)
- Kaifeng science and technology development plan (81870591, 212102310874, 222102310013, 222102310290, 23A310011, 22A310001, 2203012, 202210475148, 202210475027)
- National College Students’ innovation and entrepreneurship training program (81870591, 212102310874, 222102310013, 222102310290, 23A310011, 22A310001, 2203012, 202210475148, 202210475027)
This publication has 126 references indexed in Scilit:
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- The Antioxidant Transcription Factor Nrf2 Negatively Regulates Autophagy and Growth Arrest Induced by the Anticancer Redox Agent MitoquinoneJournal of Biological Chemistry, 2010
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cellsBiochemistry (Moscow), 2008
- Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: Synthesis and in vitro studiesBiochemistry (Moscow), 2008
- Betulinic Acid for Cancer Treatment and PreventionInternational Journal of Molecular Sciences, 2008
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionJournal of Clinical Investigation, 2007
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cellsOncogene, 1999